Low glucagon-like peptide-1 (GLP-1) concentration in serum is indicative of mild cognitive impairment in type 2 diabetes patients.

Peipei Wu,Yuxiao Zhao,Xianghua Zhuang,Aili Sun,Yuan Zhang,Yihong Ni

Clinical Neurology and Neurosurgery（2019）

引用 13|浏览7

暂无评分

摘要

•Serum GLP-1 concentration is reduced in T2DM patients.•GLP-1 concentration closely correlates with mild cognitive function impairment (MCI) in T2DM patients.•GLP-1 or its analogs are potential drugs for the prevention or treatment of MCI in patients with T2DM.

查看译文

关键词

Type 2 diabetes mellitus,Cognitive impairment,Glucagon-like peptide-1,MoCA

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要